2-Phosphoglyceric acid
2-Phosphoglyceric acid (DL-2-phosphoglyceric acid) is a glycolytic substrate that is catalyzed by enolase to form phosphoenolpyruvate ester (PEP). 2-Phosphoglyceric acid inhibits the ferroptosis pathway by down-regulating ACSL4 and up-regulating GPX4, and has significant neuroprotective effects. 2-Phosphoglyceric acid reflects the overall metabolic state and flux of the cell.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2553-59-5
- Formel: C3H7O7P
- Molecular Weight:186.06
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
ACSL4 |
Human Endogenous Metabolite |
2-Phosphoglyceric acid is significantly increased during the stationary phase of glycolysis in Lactococcus lactis, serving as a metabolic marker for the transition of cells from a state of rapid growth and active glycolysis to growth arrest or slow growth[1].
2-Phosphoglyceric acid (50-200 μM) is significantly downregulated in an oxygen-glucose deprivation/reperfusion (OGD/R)-induced injury model of mouse hippocampal neuronal cells (HT-22), and exogenous supplementation of this metabolite can effectively alleviate OGD/R-induced neuronal death[2].
2-Phosphoglyceric acid (100-200 μM) reduces intracellular Fe²⁺ accumulation and reactive oxygen species (ROS) levels in HT-22 cells, improves mitochondrial function, downregulates the expression of acyl-CoA synthetase long-chain family member 4 (ACSL4), and upregulates the expression of glutathione peroxidase 4 (GPX4) protein[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Hypoxic-ischemic brain damage (HIBD) model established in neonatal rats[2]
-
Dosage:100 and 200 μM
-
Administration:Intraventricular injection (i.c.v), single dose
-
Result:Significantly reduced the volume of cerebral infarction.
Significantly increased the number of surviving neurons in the cortex and hippocampus, and reduced neuronal damage.
Chemical Information
-
CAS. Nr. 2553-59-5
-
Molecular Weight 186.06
-
Formel C3H7O7P
-
SMILES
O=C(O)C(OP(O)(O)=O)CO
-
Synonyms
DL-2-phosphoglyceric acid
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Ramos A, et al. Relationship between glycolysis and exopolysaccharide biosynthesis in Lactococcus lactis. Appl Environ Microbiol. 2001 Jan;67(1):33-41. [Content Brief]
[2]. Chen H, et al. Metabolomics analysis revealed the neuroprotective role of 2-phosphoglyceric acid in hypoxic-ischemic brain damage through GPX4/ACSL4 axis regulation. Eur J Pharmacol. 2024 May 15;971:176539. [Content Brief]
[3]. Huang CK, et al. ENO1 and Cancer. Mol Ther Oncolytics. 2022 Jan 3;24:288-298. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
2-Phosphoglyceric acid Related Classifications
HY-113167 Related Classifications
Powered by Bioz